NAV Growth

Growth of each fund's NAV over the selected period, rebased to 0%

Growth of each fund's NAV over the selected period, rebased to 0%

‌

Fund Details

Fund Details	HDFC Pharma and Healthcare Fund - Direct (G)
Fund Type	Equity
Risk	Very High
Min SIP Amount	₹100
Min Lumpsum	₹100
Expense Ratio	1.04%
NAV	₹23.42 (11 Nov 2026)
Fund Size	₹3,665.74 Cr
Fund Started	04 Oct 2023
Lock-in Period	No lock-in
Exit Load	In respect of each purchase/Switch-in of units, an Exit load of 1% is payable if units are redeemed/switched-out within 30 days from the date of allotment. No Exit Load is payable if units are redeemed / switched-out after 30 days from the date of allotment.

Returns	HDFC Pharma and Healthcare Fund - Direct (G)
1M	8.84%
3M	5.75%
6M	19.02%
1Y	32.11%
3Y	31.39%
5Y	—
Since Inception	31.66%

Trailing risk-adjusted performance measures

Risk Ratio	HDFC Pharma and Healthcare Fund - Direct (G)
Alpha	22.22
Beta	0.66
Sharpe	1.39
Standard Deviation	4.65

Holding Analysis	HDFC Pharma and Healthcare Fund - Direct (G)
Top 5 Holdings	33.78%
Top 10 Holdings	51.70%
Portfolio Turnover	35.64
Equity	98.79%
Debt	1.77%
Cash	—

Name	Assets
Divis Laboratories LtdEquity	9.44%
Sun Pharmaceutical ...Equity	7.74%
Dr Reddys Laborator...Equity	6.66%
Apollo Hospitals En...Equity	5.19%
Alkem Laboratories LtdEquity	4.75%
Cipla LtdEquity	4.06%
Acutaas Chemicals LtdEquity	3.70%
Max Healthcare Inst...Equity	3.44%
Aster DM Quality Ca...Equity	3.37%
Torrent Pharmaceuti...Equity	3.35%

Fund Manager	HDFC Pharma and Healthcare Fund - Direct (G)
Name	, , ,

About	HDFC Pharma and Healthcare Fund - Direct (G)
AMC	HDFC Mutual Fund
Scheme Category	Sectoral Fund
Benchmark	BSE Healthcare TRI
Launch Date	14 Sept 2023